Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible
- PMID: 8100856
- PMCID: PMC1016423
- DOI: 10.1136/jmg.30.6.492
Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible
Abstract
Most forms of osteogenesis imperfecta are caused by dominant mutations in either of the two genes, COL1A1 and COL1A2, that encode the pro alpha 1(I) and pro alpha 2(I) chains of type I collagen, respectively. However, a severe, autosomal recessive form of OI type III with a comparatively high frequency has been recognised in the black populations of southern Africa. We preformed linkage analyses in eight OI type III families using RFLPs associated with the COL1A1 and COL1A2 loci to determine whether mutations in the genes for type I collagen were responsible for this form of OI. Recombination between the OI phenotype and polymorphic markers at both loci was shown in three of the eight families investigated. The combined lod scores for the eight families were -10.6 for COL1A1 and -11.2 for COL1A2. Further, we examined the type I procollagen produced by skin fibroblast cultures derived from 15 affected and 12 unaffected subjects from the above eight families plus one further family. We found no evidence for defects in the synthesis, structure, secretion, or post-translational modification of the chains of type I procollagen produced by any of the family members. These results suggest that mutations within or near the type I collagen structural genes are not responsible for this form of OI.
Similar articles
-
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2.Am J Hum Genet. 1990 Feb;46(2):293-307. Am J Hum Genet. 1990. PMID: 1967900 Free PMC article.
-
Strategy for prenatal diagnosis of osteogenesis imperfecta by linkage analysis to the type I collagen loci COL1A1 and COL1A2.Med Sci Monit. 2000 Mar-Apr;6(2):217-26. Med Sci Monit. 2000. PMID: 11208313
-
Haplotype analysis of collagen type I genes in the general population and in osteogenesis imperfecta families.Am J Med Genet. 1993 Jan 15;45(2):217-22. doi: 10.1002/ajmg.1320450213. Am J Med Genet. 1993. PMID: 8096115
-
Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.Acta Biochim Pol. 2002;49(2):433-41. Acta Biochim Pol. 2002. PMID: 12362985 Review.
-
Linkage analysis in dominantly inherited osteogenesis imperfecta.Am J Med Genet. 1993 Jan 15;45(2):212-6. doi: 10.1002/ajmg.1320450212. Am J Med Genet. 1993. PMID: 8456805 Review.
Cited by
-
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.Nat Genet. 2007 Mar;39(3):359-65. doi: 10.1038/ng1968. Epub 2007 Feb 4. Nat Genet. 2007. PMID: 17277775 Free PMC article.
-
Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice.J Cell Biol. 2010 May 3;189(3):511-25. doi: 10.1083/jcb.201003006. J Cell Biol. 2010. PMID: 20440000 Free PMC article.
-
CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis.Eur J Hum Genet. 2009 Dec;17(12):1560-9. doi: 10.1038/ejhg.2009.75. Epub 2009 Jun 24. Eur J Hum Genet. 2009. PMID: 19550437 Free PMC article.
-
A standard set of outcome measures for the comprehensive assessment of oral health and occlusion in individuals with osteogenesis imperfecta.Orphanet J Rare Dis. 2024 Aug 13;19(1):294. doi: 10.1186/s13023-024-03308-5. Orphanet J Rare Dis. 2024. PMID: 39138478 Free PMC article.
-
Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation.Eur J Pediatr. 1995 Feb;154(2):123-9. doi: 10.1007/BF01991915. Eur J Pediatr. 1995. PMID: 7720740
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous